31969330Vij R, Nath R, Afar DEH, Mateos MV, Berdeja JG, Raab MS, Guenther A, Martínez-López J, Jakubowiak AJ, Leleu X, Weisel K, Wong S, Gulbranson S, Sheridan JP, Reddy A, Paiva B, Singhal A, San-Miguel JF, Moreau PClinical cancer research : an official journal of the American Association for Cancer ResearchAntibodies, Monoclonal, Humanized; Immunoconjugates; Multiple Myeloma; Neoplasm Recurrence, Local; Signaling Lymphocytic Activation Molecule FamilyAdult; Aged; Aged, 80 and over; Cohort Studies; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prognosis; Salvage Therapy; Tissue DistributionFirst-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma. Clin Cancer Res. 2020 05 15; 26(10):2308-2317.Clin Cancer Res2020-01-22T00:00:002020First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000328Living Beings1578255770.254454AdultD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD005260Physiology1992444050.191184FemaleAuthorship 13540660.1870710.1870711authors10.2518has subject areaD015331Concepts & IdeasProcedures72727590.604878Cohort StudiesD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleD019008Physiology1805890.751147Drug Resistance, NeoplasmMedicine-Hematology and OncologyD016879Procedures972320.889684Salvage TherapyD009101Disorders823070.737453Multiple MyelomaD009364Disorders33613050.619886Neoplasm Recurrence, LocalD018796Chemicals & Drugs471060.91896ImmunoconjugatesD011379Procedures74536690.561484PrognosisD014018Concepts & Ideas1772900.949278Tissue DistributionD061067Chemicals & Drugs2139290.656201Antibodies, Monoclonal, HumanizedD0000711765150.995924Signaling Lymphocytic Activation Molecule FamilyD005500Procedures76836160.590143Follow-Up StudiesUniversity of ChicagoAndrzejJakubowiak1mhjCqp1G+POmHtvQFPt+2z5/syyp7BaZQ==Andrzej Jakubowiak41.78927490000000-87.601250000000002384Jakubowiak, AndrzejProfessortrue1ProfessorProfessor